Influence of aetiology on the effects of treatment in heart failure

J Cardiovasc Risk. 1999 Jun;6(3):131-9. doi: 10.1177/204748739900600302.
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology
  • Adrenergic beta-Antagonists / therapeutic use*
  • Adult
  • Age Factors
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Anti-Arrhythmia Agents / pharmacology
  • Anti-Arrhythmia Agents / therapeutic use*
  • Digoxin / pharmacology
  • Digoxin / therapeutic use*
  • Diuretics / pharmacology
  • Diuretics / therapeutic use*
  • Heart Failure / drug therapy*
  • Heart Failure / etiology*
  • Humans
  • Middle Aged
  • Myocardial Infarction / prevention & control
  • Prognosis

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Anti-Arrhythmia Agents
  • Diuretics
  • Digoxin